Prevnar 13 Loses ‘Routine’ Endorsement For Older Adults In CDC Panel Vote

 
• By Sue Sutter

ACIP still supports use of Pfizer’s pneumococcal vaccine in immunocompetent individuals ages 65 years and older based on shared clinical decision-making, but concludes that routine immunization is no longer warranted due to herd effect from pediatric vaccination.

Streptococcus pneumoniae or pneumococcus bacterias. 3d illustration - Illustration
ACIP voted to move away from routine use of Prevnar 13 in older adults to prevent invasive disease caused by Streptococcus pneumoniae. • Source: Shutterstock

More from Vaccines

More from Pink Sheet